Related Experiment Video

Updated: Jun 30, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors

Martin G Belinsky1, Lori Rink, Kathy Q Cai

  • 1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

Cell Cycle (Georgetown, Tex.)
|September 27, 2008
PubMed

Insights

Gastrointestinal stromal tumors (GISTs) often have KIT or PDGFRalpha mutations. This study explores the insulin-like growth factor (IGF) pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastrointestinal stromal tumors (GISTs) are primarily driven by mutations in receptor tyrosine kinases (RTKs) like c-KIT and PDGFRalpha.
  • Imatinib mesylate (IM) has significantly improved GIST treatment, but a subset of patients do not respond.
  • The genetic drivers for IM-refractory GISTs lacking common mutations remain largely unknown.

Purpose of the Study:

  • To investigate the role of the insulin-like growth factor (IGF) signaling pathway in GIST pathogenesis.
  • To identify potential new therapeutic targets within the IGF pathway for IM-resistant GISTs.

Main Methods:

  • Analysis of gene amplification for insulin-like growth factor 1 receptor (IGF-1R) in GISTs.
  • Assessment of IGF-1R protein expression in various GIST subtypes.
  • Review of existing literature on IGF pathway involvement in GISTs.

Main Results:

  • Gene amplification of IGF-1R was identified in a subset of GISTs.
  • IGF-1R protein is overexpressed in wild-type and pediatric GISTs.
  • The insulin-like growth factor signaling pathway is implicated in GIST development.

Conclusions:

  • The IGF pathway plays a significant role in the pathogenesis of certain GISTs.
  • Components of the IGF pathway represent promising molecular targets for treating IM-refractory GISTs.
  • Further research into IGF pathway modulation could lead to novel GIST therapies.

More Related Videos

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...